JP2016510727A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510727A5
JP2016510727A5 JP2015558916A JP2015558916A JP2016510727A5 JP 2016510727 A5 JP2016510727 A5 JP 2016510727A5 JP 2015558916 A JP2015558916 A JP 2015558916A JP 2015558916 A JP2015558916 A JP 2015558916A JP 2016510727 A5 JP2016510727 A5 JP 2016510727A5
Authority
JP
Japan
Prior art keywords
abcb5
stem cells
isolated
ocular
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015558916A
Other languages
English (en)
Other versions
JP7027026B2 (ja
JP2016510727A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/017076 external-priority patent/WO2014130518A1/en
Publication of JP2016510727A publication Critical patent/JP2016510727A/ja
Publication of JP2016510727A5 publication Critical patent/JP2016510727A5/ja
Application granted granted Critical
Publication of JP7027026B2 publication Critical patent/JP7027026B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (16)

  1. 目の異常の処置に使用するための単離されたABCB5(+)幹細胞を含有する組成物であって、対象の眼細胞を再生するために有効な量の単離されたABCB5(+)幹細胞がその必要がある前記対象に投与される、前記組成物。
  2. 眼の異常が角膜疾患、網膜疾患または眼創傷である、請求項1に記載の組成物。
  3. 角膜疾患が角膜上皮幹細胞疲弊症(LSCD)を原因とする盲目である、請求項2に記載の組成物。
  4. 網膜疾患が黄斑変性または網膜炎である、請求項2に記載の組成物。
  5. 単離されたABCB5(+)幹細胞が眼移植片として投与される、請求項1〜4のいずれか一項に記載の組成物。
  6. 単離されたABCB5(+)幹細胞が同種他家由来幹細胞である、請求項1〜5のいずれか一項に記載の組成物。
  7. 単離されたABCB5(+)幹細胞が同系幹細胞、ABCB5(+)眼幹細胞もしくはABCB5(+)角膜輪部幹細胞であるかまたは皮膚幹細胞ではない、請求項1〜6のいずれか一項に記載の組成物。
  8. 眼細胞の混合集団から角膜輪部幹細胞を単離する方法であって、
    眼細胞の混合集団を提供すること;および
    混合集団からABCB5(+)角膜輪部幹細胞を単離すること
    を含み、
    前記ABCB5(+)角膜輪部幹細胞は任意にヒトABCB5に選択的に結合する抗体と単離される、前記方法。
  9. 対象への移植用の眼移植片を作製する方法であって、単離されたABCB5(+)幹細胞を基質に播種して、眼移植片を作製することを含む方法。
  10. 基質がフィブリンゲル、羊膜、アミノグリカン、またはその組み合わせを含む、請求項に記載の方法。
  11. 対象への移植用の単離されたABCB5(+)幹細胞が濃縮された眼移植片。
  12. 目の異常の処置に使用するための単離されたABCB5(+)幹細胞が濃縮された眼移植片。
  13. 単離されたABCB5(+)幹細胞が同種他家由来幹細胞、同系幹細胞、ABCB5(+)眼幹細胞もしくはABCB5(+)角膜輪部幹細胞であるかまたは皮膚幹細胞でない、請求項12に記載の眼移植片。
  14. 眼細胞再生の促進に使用するための単離されたABCB5(+)角膜輪部幹細胞を含有する組成物であって、角膜輪部幹細胞がABCB5(+)角膜輪部幹細胞として同定され、および眼細胞再生を促進するために有効な量のABCB5(+)角膜輪部幹細胞がその必要がある対象に投与される、前記組成物。
  15. 単離されたABCB5(+)角膜輪部幹細胞が眼移植片として投与される、請求項13に記載の組成物。
  16. 角膜輪部幹細胞の単離された調製物であって、細胞表面上のABCB5の発現を特徴とする前記調製物。
JP2015558916A 2013-02-19 2014-02-19 眼疾患を処置するためのabcb5(+)幹細胞 Active JP7027026B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361766424P 2013-02-19 2013-02-19
US61/766,424 2013-02-19
PCT/US2014/017076 WO2014130518A1 (en) 2013-02-19 2014-02-19 Abcb5(+) stem cells for treating ocular disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019036040A Division JP2019189600A (ja) 2013-02-19 2019-02-28 眼疾患を処置するためのabcb5(+)幹細胞

Publications (3)

Publication Number Publication Date
JP2016510727A JP2016510727A (ja) 2016-04-11
JP2016510727A5 true JP2016510727A5 (ja) 2017-03-30
JP7027026B2 JP7027026B2 (ja) 2022-03-01

Family

ID=51391751

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015558916A Active JP7027026B2 (ja) 2013-02-19 2014-02-19 眼疾患を処置するためのabcb5(+)幹細胞
JP2019036040A Pending JP2019189600A (ja) 2013-02-19 2019-02-28 眼疾患を処置するためのabcb5(+)幹細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019036040A Pending JP2019189600A (ja) 2013-02-19 2019-02-28 眼疾患を処置するためのabcb5(+)幹細胞

Country Status (9)

Country Link
US (3) US9801912B2 (ja)
EP (2) EP2964238B1 (ja)
JP (2) JP7027026B2 (ja)
KR (2) KR102474489B1 (ja)
AU (1) AU2014219026B2 (ja)
CA (1) CA2901931C (ja)
DK (1) DK2964238T3 (ja)
ES (1) ES2860573T3 (ja)
WO (1) WO2014130518A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3333182A1 (en) 2000-06-05 2018-06-13 The Brigham and Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
DK2035549T3 (da) 2006-05-31 2014-10-13 Childrens Medical Center Abcb5-positive mesenkymale stamceller som immunmodulatorer
JP5889527B2 (ja) 2007-04-12 2016-03-22 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. 癌療法のためのabcb5標的化
EP3978928A1 (en) 2008-11-14 2022-04-06 The Brigham and Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
KR102474489B1 (ko) * 2013-02-19 2022-12-06 칠드런'즈 메디컬 센터 코포레이션 안구 질환을 치료하기 위한 abcb5(+) 줄기 세포
AU2014262590B2 (en) * 2013-05-10 2018-05-10 Children's Medical Center Corporation Wound healing and tissue engineering
KR20180120670A (ko) * 2015-11-13 2018-11-06 아벨리노 랩 유에스에이, 인크. 각막 이상증의 치료 방법
US20220387668A1 (en) * 2019-11-07 2022-12-08 Massachusetts Eye And Ear Infirmary Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation
EP3842079A1 (en) * 2019-12-24 2021-06-30 Universiteit Antwerpen Ophthalmological device for the treatment of lscd and substrate for use in same
EP4125960A4 (en) * 2020-03-30 2024-04-03 Childrens Medical Center USE OF STEM CELLS FOR THE TREATMENT OF EXCESSIVE INFLAMMATION
WO2023014892A1 (en) * 2021-08-04 2023-02-09 Alpine Biotherapeutics Corporation Sustainable ocular cell-mediated intraocular delivery of cellular therapeutics for treatment of ocular diseases or disorders
KR20230129828A (ko) 2022-03-02 2023-09-11 포항공과대학교 산학협력단 안구 후방 질환 또는 손상의 예방 또는 치료용 조성물
KR20230130479A (ko) 2022-03-03 2023-09-12 서울대학교병원 안구건조증 또는 마이봄샘 기능장애의 예방, 개선, 또는 치료용 조성물
CN115074368B (zh) * 2022-06-09 2023-08-08 澳门科技大学 一种耐药型类风湿性关节炎动物模型的构建及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434075A (en) 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
EP0906415B1 (en) 1996-04-19 2009-08-19 Osiris Therapeutics, Inc. Regeneration and augmentation of bone using mesenchymal stem cells
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
DE19722075C1 (de) 1997-05-27 1998-10-01 Wilhelm Dr Med Fleischmann Vorrichtung zur Applikation von Wirkstoffen an einer Wundoberfläche
DE69922933T2 (de) 1998-03-13 2005-12-29 Osiris Therapeutics, Inc. Anwendungen für humane nicht autologe, mesenchymale stammzellen
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6797269B2 (en) 1998-04-03 2004-09-28 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
WO1999061587A1 (en) 1998-05-29 1999-12-02 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
CA2390131C (en) 1999-11-29 2009-06-23 Hill-Rom Services, Inc. Wound treatment apparatus
EP3333182A1 (en) 2000-06-05 2018-06-13 The Brigham and Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
AU2002211389A1 (en) 2000-10-03 2002-04-15 California Institute Of Technology Microfluidic devices and methods of use
WO2002083046A1 (en) 2001-04-16 2002-10-24 Pamela Howard Wound dressing system
US6905678B2 (en) 2001-07-07 2005-06-14 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
US8034904B2 (en) 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
WO2006103685A2 (en) * 2005-03-28 2006-10-05 Vision Research Foundation A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
IL286053B2 (en) 2005-10-18 2023-03-01 Nat Jewish Health A process for making red blood cells using immortal hematopoietic stem cells and erythropoietin
DK2035549T3 (da) 2006-05-31 2014-10-13 Childrens Medical Center Abcb5-positive mesenkymale stamceller som immunmodulatorer
GB0610778D0 (en) 2006-05-31 2006-07-12 Het Nl Kanker I Phosphatidylinositol phospahte and apoptosis
JP5889527B2 (ja) 2007-04-12 2016-03-22 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. 癌療法のためのabcb5標的化
US9011840B2 (en) 2008-03-14 2015-04-21 The Board Of Trustees Of The University Of Illinois Activated mesenchymal stem cells for wound healing and impaired tissue regeneration
EP3978928A1 (en) 2008-11-14 2022-04-06 The Brigham and Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
WO2010065711A1 (en) 2008-12-04 2010-06-10 Adimab, Inc. An abcb5 epitope and antibodies thereto for the treatment of cancer
GB0908927D0 (en) * 2009-05-22 2009-07-01 Univ Reading The Synthetic graft
WO2013002953A1 (en) 2011-06-01 2013-01-03 The Board Of Trustees Of The University Of Illinois Membrane-scaffold composites for tissue engineering applications
KR102474489B1 (ko) 2013-02-19 2022-12-06 칠드런'즈 메디컬 센터 코포레이션 안구 질환을 치료하기 위한 abcb5(+) 줄기 세포
AU2014262590B2 (en) 2013-05-10 2018-05-10 Children's Medical Center Corporation Wound healing and tissue engineering
US20180134771A1 (en) 2015-05-07 2018-05-17 Bioxcel Corporation Novel immunomodulatory therapeutic strategies targeting tumors in cancer

Similar Documents

Publication Publication Date Title
JP2016510727A5 (ja)
PH12018500401A1 (en) Antibodies specific for tgf-beta
JP2018086274A5 (ja)
JP2016520068A5 (ja)
JP2015096556A5 (ja)
WO2018098365A3 (en) Compositions and methods for tcr reprogramming using fusion proteins
JP2015131795A5 (ja)
MX348245B (es) Tratamiento de la degeneracion del disco intervertebral mediante el uso de celulas humanas derivadas de tejido del cordon umbilical.
AU2016277883A8 (en) PD-1-CD28 fusion proteins and their use in medicine
PH12017502283A1 (en) A method of treatment
JP2010285434A5 (ja)
JP2016515522A5 (ja)
EA201301277A1 (ru) Композиции и способы лечения заболеваний сетчатки
JP2015521054A5 (ja)
WO2013013025A3 (en) Anti-cxcr4 antibodies and methods of use
WO2015191934A3 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
JP2016539641A5 (ja)
BR112018012070A2 (ja) A manufacturing method of an organization and internal organs using blood cells
ZA201907371B (en) Methods and compositions for treating allergic ocular diseases
WO2012079088A3 (en) Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
WO2014028668A3 (en) Stem cell enhancing therapeutics
WO2015076717A3 (en) Mscs in the treatment of cardiac disorders
WO2019004792A3 (ko) 인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
WO2013067076A3 (en) Methods and compositions for neuroprotection